The Histamine H4 Receptor: A Novel Target for Safe Anti-inflammatory Drugs?
DOI:
https://doi.org/10.17140/GOJ-1-103Keywords:
Histamine H4 receptor, Stomach, IntestineAbstract
The functional role of histamine H4 receptors (H4 Rs) in the Gastrointestinal (GI) tract is reviewed, with particular reference to their involvement in the regulation of gastric mucosal defense and inflammation. H4 Rs have been detected in different cell types of the gut, including immune cells, paracrine cells, endocrine cells and neurons, from different animal species and humans; moreover, H4 R expression was reported to be altered in some pathological conditions, such as colitis and cancer. Functional studies have demonstrated protective effects of H4R antagonists in several experimental models of gastric mucosal damage and intestinal inflammation, suggesting a potential therapeutic role of drugs targeting this new receptor subtype in GI disorders, such as allergic enteropathy, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS) and cancer.
References
Black JW, Duncan WA, Durant CJ, Ganellin CR, Parsons EM. Definition and antagonism of histamine H2-receptors. Nature. 1972; 236: 385-390. doi: 10.1038/236385a0
Feldman M, Burton ME. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. First part.N Engl J Med. 1990; 323: 1672-1680. doi: 10.1056/NEJM199012133232405
Feldman M, Burton ME. Histamine2-receptor antago-nists. Standard therapy for acid-peptic diseases. Second part. N Engl J Med. 1990; 323: 1749-1755. doi: 10.1056/ NEJM199012203232507
Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptors. Nature. 1983; 302: 832-837. doi: 10.1038/302832a0
Vohora D. The third Histamine Receptor: Selective Ligands as Potential Therapeutic Agents in CNS Disorders. Boca Raton, FL (USA); CRC Press, Taylor and Francis Group; 2008.
Leurs R, Chazot PL, Shenton FC, Lim HD, de Esch IJ. Mo-lecular and biochemical pharmacology of the histamine H4 re-ceptor. Br J Pharmacol. 2009; 157: 14-23. doi: 10.1111/j.1476- 5381.2009.00250.x
Zampeli E, Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol. 2009; 157: 24-33. doi: 10.1111/j.1476-5381.2009.00151.x
Stark H. Histamine H4 receptor: a novel target in immuno-regulation and inflammation. London, Great Britain; Versita Ltd; 2013.
Celanire S, Wijtmans M, Talaga P, Leurs R, de Esch IJ. Key-note review: histamine H3 receptor antagonists reach out for the clinic. Drug Discov Today. 2005; 10: 1613-1627. doi: 10.1016/ S1359-6446(05)03625-1
Passani MB, Blandina P, Torrealba F. The histamine H3 re-ceptor and eating behaviour. J Pharmacol Exp Ther. 2011; 336: 24-29. doi: 10.1124/jpet.110.171306
Thurmond RL, Gelfand EW, Dunford PJ. The role of hista-mine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov. 2008; 7: 41-53. doi: 10.1038/nrd2465
Engelhardt H, Smits RA, Leurs R, Haaksma E, de Esch IJ. A new generation of anti-histamines: Histamine H4 receptor antagonists on their way to the clinic. Curr Opin Drug Discov Devel. 2009; 12: 628-643.
Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself? Physiol Rev. 2008; 88: 1547-1565. doi: 10.1152/physrev.00004.2008
Wallace JL. COX-2: a pivotal enzyme in mucosal protection and resolution of inflammation. Scientific World Journal. 2006; 6: 577-588.doi: http://dx.doi.org/10.1100/tsw.2006.122
Whittle BJ. Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors. Eur J Pharmacol. 2004; 500: 427-439. doi: 10.1016/j.ejphar.2004.07.042
Wallace JL. Mechanisms, prevention and clinical implica-tions of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol. 2013; 19: 1861-1876. doi: 10.3748/wjg.v19. i12.1861
Zhang M, Thurmond RL, Dunford PJ. The histamine H4 receptor: a novel modulator of inflammatory and immune dis-orders. Pharmacol Ther. 2007; 113: 594-606. doi: 10.1016/j. pharmthera.2006.11.008
Strakhova MI, Cuff CA, Manelli AM, et al. In vitro and in vivo characterization of A-940894: a potent histamine H4 recep-tor antagonist with anti-inflammatory properties. Br J Pharma-col. 2009; 157: 44-54. doi: 10.1111/j.1476-5381.2009.00236.x
Takeshita K, Sakai K, Bacon KB, Gantner F. Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymo-san in vivo. J Pharmacol Exp Ther. 2003; 307: 1072-1078. doi: 10.1124/jpet.103.057489
Bell JK, McQueen DS, Rees JL. Involvement of histamine H4 and H1 receptors in scratching induced by histamine recep-tor agonists in Balb C mice. Br J Pharmacol. 2004; 142: 374- 380. doi: 10.1038/sj.bjp.0705754
Thurmond RL, Desai PJ, Dunford PJ, et al. A potent and se-lective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther. 2004; 309: 404-413. doi: 10.1124/jpet.103.061754
Coruzzi G, Adami M, Guaita E, de Esch IJ, Leurs R. Anti-inflammatory and antinociceptive effects of the selective hista-mine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation.Eur J Phar-macol. 2007; 563: 240-244.doi: 10.1016/j.ejphar.2007.02.026
Ahmad SF, Zoheir KM, Abdel-Hamied HE, et al. The role of a histamine 4 receptor as an anti-inflammatory target in car-rageenan-induced pleurisy in mice. Immunology. 2014; Jan 25. doi: 10.1111/imm.12257.
Hsieh GC, Chandran P, Salyers AK, et al. H4 receptor an-tagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacol Biochem Behav. 2010; 95: 41-50. doi: 10.1016/j.pbb.2009.12.004
de Esch IJ, Thurmond RL, Jongejan A, Leurs R. The hista-mine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci. 2005; 26: 462-469. doi: http://dx.doi. org/10.1016/j.tips.2005.07.002
Jablonowski JA, Grice CA, Chai W, et al. The first potent and selective non-imidazole human histamine H4 receptor an-tagonists. J Med Chem. 2003; 46: 3957-3960. doi: 10.1021/ jm0341047
Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 recep-tor agonist. J Pharmacol Exp Ther. 2005; 314: 1310-1321. doi: 10.1124/jpet.105.087965
Lim HD, Smits RA, Bakker RA, van Dam CM, de Esch IJ, Leurs R. Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole H4 receptor agonist. J Med Chem. 2006; 49: 6650-6651. doi: 10.1021/jm060880d
Rosethorne EM, Charlton SJ. Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits β-arrestin without activating G proteins. Mol Pharmacol. 2011; 79: 749-757. doi: 10.1124/mol.110.068395
Seifert R, Schneider EH, Dove S, et al. Paradoxical stimula-tory effects of the “standard” histamine H4-receptor antagonist JNJ7777120: the H4 receptor joins the club of 7 transmembrane domain receptors exhibiting functional selectivity. Mol Pharma-col. 2011; 79: 631-638. doi: 10.1124/mol.111.071266
Neumann D, Beermann S, Seifert R. Does the histamine H4 receptor have a pro- or anti-inflammatory role in murine bronchial asthma? Pharmacology. 2010; 85: 217-223. doi: 10.1159/000285088
Adachi N, Liu K, Motoki A, Nishibori M, Arai T. Suppres-sion of ischemia/reperfusion liver injury by histamine H4 recep-tor stimulation in rats. Eur J Pharmacol. 2006; 544: 181-187. doi: 10.1016/j.ejphar.2006.06.053
Coruzzi G, Pozzoli C, Adami M, et al. Strain-dependent ef-fects of the histamine H4 receptor antagonist JNJ7777120 in a murine model of acute skin inflammation. Exp Dermatol. 2012: 21: 32-37. doi: 10.1111/j.1600-0625.2011.01396.x
Schreeb A, Lazewska D, Dove S, Buschauer A, Kiec-Ko-nonowicz K, Stark H. Histamine H4 receptor ligands. In: Stark H, ed. Histamine H4 receptor: a novel drug target in immuno-regulation and inflammation. London, Great Britain: Versita Ltd; 2013: 21-61.
Coruzzi G, Adami M, Pozzoli C. Role of histamine H4 re-ceptors in the gastrointestinal tract. Front Biosci. 2012; 4: 226- 239.
Yu S, Stahl E, Li Q, Ouyang A. Antigen inhalation induces mast cells and eosinophils infiltration in the guinea pig esopha-geal epithelium involving histamine-mediated pathway. Life Sci. 2008; 82: 324-330. doi: 10.1016/j.lfs.2007.12.002
Morini G, Becchi G, Shenton FC, Chazot PL, Grandi D. Histamine H3 and H4 receptors are expressed on distinct en-docrine cell types in the rat fundic mucosa. Inflamm Res. 2008; 57(Suppl. 1): S57-S58. doi: 10.1007/s00011-007-0628-9
Liu C, Ma X, Jiang X, Wilson SJ, Hofstra CL, Blevitt J. Cloning and pharmacological characterization of a fourth hista-mine receptor (H4) expressed in bone marrow. Mol Pharmacol. 2001; 59: 420-426. doi: 10.1124/mol.59.3.420
Zhang C, Xiong Y, Li J, et al. Deletion and down-regulation of HRH4 gene in gastric carcinomas: a potential correlation with tumor progression. PLoS One. 2012; 7: e31207. doi: 10.1371/ journal.pone.0031207
Takagaki K, Osawa S, Horio Y, et al. Cytokine responses of intraepithelial lymphocytes are regulated by histamine H2 receptor. J Gastroenterol. 2009; 44: 285-296. doi: 10.1007/ s00535-009-0019-9
Chazot PL, Shenton FC, Waldvogel H, Grandi D, Morini G. The H4 histamine receptor is expressed in both the human CNS and rodent PNS. In: European Histamine Research Society, 36th Annual Meeting, Florence (Italy), May 9-12th, 2007: 27.
Jiang W, Lim HD, Zhang M, et al. Cloning and pharmacologi-cal characterization of the dog histamine H4 receptor. Eur J Phar-macol. 2008; 592: 26-32. doi: 10.1016/j.ejphar.2008.06.095
Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K. Mo-lecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun. 2000; 279: 615-620.doi: 10.1006/bbrc.2000.4008
Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S. Mo-lecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem. 2000; 275: 36781-36786. doi: 10.1074/jbc.M006480200
Cogè F, Guenin SP, Rique H, Boutin JA, Galizzi JP. Structure and expression of the human histamine H4-receptor gene. Bio-chem Biophys Res Commun. 2001; 284: 301-309. doi: 10.1006/ bbrc.2001.4976
Morse KL, Behan J, Laz TM, et al. Cloning and character-ization of a novel human histamine receptor. J Pharmacol Exp Ther. 2001; 296: 1058-1066.
Sander LE, Lorentz A, Sellge G, et al. Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. Gut. 2006; 55: 498-504.
Kumawat AK, Gotlind YY, Fredin MF, Willen R, Strid H, Hultgren-Hornquist E. Expression patterns of histamine recep-tors in the Gαi2-deficient mouse model of colitis. Inflamm Res. 2010; 59(Suppl. 4): S358-S359.
Sutton TL, Zhao A, Madden KB, et al. Antiinflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a mu-rine model. Infect Immun. 2008; 76: 4772-4782. doi: 10.1128/ IAI.00744-07
Eisenschenk MNC, Torres SM, Oliveira S, Been CS. The expression of histamine H4 receptor mRNA in the skin and other tissues of normal dogs. Vet Dermatol. 2011; 22: 396-400. doi: 10.1111/j.1365-3164.2011.00959.x
Oda T, Matsumoto S, Masuho Y, et al. cDNA cloning and characterization of porcine histamine H4 receptor. Biochim Biophys Acta. 2002; 1575: 135-138. doi: 10.1016/S0167-4781- (02)00236-1
Oda T, Matsumoto S, Matsumoto M, et al. Molecular clon-ing of monkey histamine H4 receptor. J Pharmacol Sci. 2005; 98: 319-322. doi: 10.1254/jphs.SC0050033
Kim H, Dwyer L, Song JH, et al. Identification of histamine receptors and effects of histamine on murine and simian colonic excitability. Neurogastroenterol Motil. 2011; 23: e949-e409. doi: 10.1254/jphs.SC0050033
Cianchi F, Cortesini C, Schiavone NF, et al. The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin Cancer Res. 2005; 11: 6807-6815. doi: 10.1158/1078-0432.CCR-05-0675
Boer K, Helinger E, Helinger A, et al. Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine. Eur J Cell Biol. 2008; 87: 227-236. doi: 10.1016/j.ejcb.2007.12.003
Fang Z, Yao W, Xiong Y, et al. Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression. BMC Cancer. 2011; 11: 195-205. doi: 10.1186/1471-2407-11-195
Coruzzi G, Adami M, Pozzoli C, Smits R, de Esch IJP, Leurs R. Gastroprotective effects of histamine H4 receptor li gands in rodent ulcer models. Br J Pharmacol. 2010; 7: 150P.
Adami M, Pozzoli C, Menozzi A, et al. Effects of histamine H4 receptor ligands in a mouse model of gastric ulceration. Pharmacology. 2012; 89: 287-294.doi: 10.1159/000337736
Varga C, Horvath K, Berko A, Thurmond RL, Dunford PJ, Whittle BJ. Inhibitory effects of histamine H4 receptor antago-nists on experimental colitis in the rat. Eur J Pharmacol. 2005; 522: 130-138. doi: 10.1016/j.ejphar.2005.08.045
Dunford PJ, Varga, C, Thurmond RL, Whittle BJ. Histamine H4 receptor antagonism attenuates toll-like receptor signaling and inhibits experimental colitis in the rat. Gastroenterology. 2006; 130: A-689.
Fogel WA, Jochem J, Lewinski A. Influence of the H3/H4 receptor antagonist, thioperamide on regional haemodinamics in rats with trinitrobenzene sulfonic acid-induced colitis. Inflamm Res. 2007; 56 (Suppl. 1): S21-S22. doi: 10.1007/s00011-006- 0510-1
Cowart MD, Altenbach RJ, Liu H, et al. Rotationally con-strained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglike-ness and in vivo efficacy in pain and inflammation models. J Med Chem. 2008; 51: 6547-6557. doi: 10.1021/jm800670r
Liu H, Altenbach RJ, Carr TL, et al. cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2- amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. J Med Chem. 2008; 51: 7094-7098. doi: 10.1021/jm8007618
Strakhova MI, Cuff CA, Manelli AM, et al. In vitro and in vivo characterization of A-940894: a potent histamine H4 recep-tor antagonist with anti-inflammatory properties. Br J Pharma-col. 2009; 157: 44-54. doi: 10.1111/j.1476-5381.2009.00236.x
Medina V, Cricco G, Mohamad N, et al. Histamine is a se-lective protector against cellular damage produced by ioniz-ing radiation. Inflamm Res. 2005; 54(Suppl. 1): S17-S18. doi: 10.1007/s00011-004-0407-9
Ghizzardi P, Gobbetti T, Bertoni S, et al. Histamine H4 re-ceptor antagonism and mesenteric ischemia/reperfusion injury in mice. Gastroenterology. 2009; 136 (Suppl. 1): A-397. doi:
Deiteren A, De Man JG, Ruyssers NE, Moreels TG, Pelck-mans PA, De Winter BY. Histamine H4 and H1 receptors con-tribute to postinflammatory visceral hypersensitivity. Gut. 2014; Feb 21. doi: 10.1136/gutjnl-2013-305870.
Coruzzi G, Adami M, Pozzoli C, de Esch IJ, Smits R, Leurs R. Selective histamine H3 and H4 recep-tor agonists exert opposite effects against the gastric le-sions induced byHCl in the rat stomach. Eur J Pharma-col. 2011; 669: 121-127. doi: 10.1016/j.ejphar.2011.07.038
Coruzzi G, Adami M. Peripheral actions and therapeu-tic potential in periphery. In: Vohora D, ed. The third His-tamine Receptor: Selective Ligands as Potential Thera-peutic Agents in CNS Disorders. New York, NY, USA: CRC Press, Taylor and Francis Group; 2008: 167-209.
Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol. 1990; 259: G462-G467.
Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experi-mental models of inflammatory bowel disease. Gastroenterol-ogy. 1995; 109: 1344-1367. doi: http://dx.doi.org/10.1016/0016- 5085(95)90599-5
Raithel M, Matek M, Baenkler HW, Jorde W, Hahn EG. Mu-cosal histamine content and histamine secretion in Crohn’s dis-ease, ulcerative colitis and allergy enteropathy. Int Arch Allergy Immunol. 1995; 108: 127-133.
Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004; 126: 693-702.doi: http://dx.doi.org/10.1053/j.gastro.2003.11.055
Medina VA, Coruzzi G, Martinal Lamas DJ, et al. Histamine in cancer. In: Stark H ed. Histamine H4 receptor: a novel drug target in immunoregulation and inflammation. London, Great Britain, Versita Ltd. 2013; 259-308.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Gastro (GOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.